Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca at 700 Progress Way in Gaithersburg, MD
Part of a recently delivered 44-acre life science and industrial campus FREDERICK, Md., Dec. 6, 2023 /PRNewswire-PRWeb/ -- Matan Companies, a leading real estate development and investment firm, announced today the successful execution of a full-building lease agreement with AstraZeneca,... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 6, 2023 Category: Pharmaceuticals Tags: LIC Source Type: news
European Pharmas With New Drugs Hold Most Promise in 2024
European pharmaceutical and biotech companies with new drugs and higher growth prospects look the best investment bets in the sector in 2024, JPMorgan says. JPM is avoiding companies like Bayer and Roche, which might struggle to match 2024…#jpmorgan #jpm #bayer #roche #gsk #novonordisk #astrazeneca #merck #argenx #morphosys (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news
The weight-loss drug gold rush is getting larger
More drug companies are racing to join what's been a two-horse race to make blockbuster obesity drugs, snapping up smaller biotechs and vying for a market that could be worth tens of billions in less than a decade. Why it matters: GLP-1 agonists like Novo Nordisk's Wegovy and Ozempic have soared…#glp1 #novonordisk #wegovyandozempic #medicare #zuercherkantonalbank #roche #carmottherapeutics #obese #carmot #astrazeneca (Source: Reuters: Health)
Source: Reuters: Health - December 5, 2023 Category: Consumer Health News Source Type: news
Absci announces another partnership with a major drugmaker
Absci's collaboration with AstraZeneca is intended to advance an AI-driven oncology candidate. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 4, 2023 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
AstraZeneca teams up with West Coast AI company to develop new cancer drugs
The company's platform accelerates drug discovery by completing the cycle of data collection, AI-driven design, and wet-lab validation within an estimated six weeks. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 4, 2023 Category: Biotechnology Authors: John George Source Type: news
AstraZeneca, AI biologics firm Absci tie up on cancer drug
The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Dec 3 (Reuters) - Anglo-Swedish drugmaker AstraZeneca…#astrazeneca #belgium #anglo #seanmcclain (Source: Reuters: Health)
Source: Reuters: Health - December 4, 2023 Category: Consumer Health News Source Type: news
AstraZeneca ties up with AI biologics company to develop cancer drug
(Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news
AstraZeneca, AI biologics firm Absci tie up on cancer drug - FT
The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron/File Photo Acquire Licensing Rights Dec 3 (Reuters) - Anglo-Swedish drugmaker AstraZeneca…#astrazeneca #belgium #anglo #seanmcclain (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news
AstraZeneca ties up with AI biologics company to develop cancer drug
Deal with Absci is the latest between big pharma and tech companies to build new disease treatments (Source: Reuters: Health)
Source: Reuters: Health - December 3, 2023 Category: Consumer Health News Source Type: news
TRUQAP (capivasertib), FDA Approved for the Treatment of Breast Cancer, Available at Biologics by McKesson
CARY, N.C., Dec. 1, 2023 —Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by AstraZeneca as a specialty pharmacy provider for TRUQAPTM (capivasertib). TRUQAP, which was approved by the U.S. Food and Drug Administration (FDA) on Nov. 17... (Source: McKesson News)
Source: McKesson News - December 1, 2023 Category: Information Technology Source Type: news
News at a glance: Lower pay for disabled Ph.D.s, more U.K. genomes, and quitting antismoking rules
LEADERSHIP
Argentina’s president targets science
The election last week of libertarian Javier Milei as Argentina’s next president has many of the nation’s scientists fearing the future. Milei, who won 55.7% of the vote, has
vowed to close or dramatically restructure the National Scientific and Technical Research Council
(CONICET), Argentina’s main science funding agency, and its health and environment ministries. He views climate change as a “socialist hoax.” Milei has called CONICET, which employs nearly 12,000 researchers and ranks as one of South America’s top government s...
Source: ScienceNOW - November 30, 2023 Category: Science Source Type: news
Lab Notes: AstraZeneca launches new business; Palvella receives key FDA designation
This week's Lab Notes has items on a Big Pharma company's new business launch, a contract research organization's expanding service line, a Wayne biopharma firm's key Food and Drug Administration designation, and more. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 24, 2023 Category: Pharmaceuticals Authors: John George Source Type: news
AstraZeneca rejects claims its Covid vaccine was 'defective': Jab maker argues accusations are 'confused' and 'wrong in law'
While the jab was rolled out successfully to millions in Britain, a fraction (including Jamie Scott, pictured) suffered from a severe blood clot complication missed in the jab's original clinical trials. (Source: the Mail online | Health)
Source: the Mail online | Health - November 23, 2023 Category: Consumer Health News Source Type: news
AstraZeneca launches Evinova to bring AI to clinical trials
The pharma giant ' s new health tech company will operate as a separate business and scale the company ' s already established digital technologies to enhance clinical trials. (Source: mobihealthnews)
Source: mobihealthnews - November 22, 2023 Category: Information Technology Source Type: news
AstraZeneca fights accusations its Covid-19 jab was ‘defective’
Vaccine recipient claims he suffered side effect of severe blood clot (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 22, 2023 Category: Pharmaceuticals Source Type: news
